MeSH Browser

MeSH Heading: Amlodipine Besylate, Olmesartan Medoxomil Drug Combination
Tree Number(s): D03.383.129.308.674.500; D03.383.129.617.584.500; D03.383.725.203.065.500; D26.310.063
Unique ID: D000068558
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000068558
Scope Note: A pharmaceutical preparation of amlodipine besylate and olmesartan medoxomil that combines ANGIOTENSIN II TYPE I RECEPTOR ANTAGONIST and CALCIUM CHANNEL BLOCKER activities. It is used in the management of HYPERTENSION.
Entry Term(s): Amlodipine Besylate, Olmesartan Medoxomil; Amlodipine Besylate-Olmesartan Medoxomil; Amlodipine Besylate-Olmesartan Medoxomil Drug Combination; Azor
Pharm Action: Antihypertensive Agents
Calcium Channel Blockers
Angiotensin II Type 1 Receptor Blockers
Registry Number: 0
Previous Indexing: Amlodipine (2010-2015); Antihypertensive Agents (2012-2015)
Public MeSH Note: 2016
History Note: 2016
Date Established: 2016/01/01
Date of Entry: 2015/07/01
Revision Date: 2016/05/27

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Amlodipine Besylate, Olmesartan Medoxomil Drug Combination MeSH Descriptor Data 2023